Neoplasia/BPH

	Use of Single-Cell Data and scPagwas Analysis to Identify T Cell Subsets and Construct a Prognostic Model for Clear Cell Renal Cell Carcinoma. Hum Mutat Yi X, Jia Z, Wu J, Wang S, Yu Y, Kong Y, He X, Huang Y. PMID: 41960370 [PubMed - in process]
	Periodic intrafraction image-guided focal dose-escalated stereotactic body radiotherapy for prostate carcinoma on a standard linear accelerator. Phys Imaging Radiat Oncol Serpa M, Wiehle R, Rothe T, Küchler S, Fechter T, Sachpazidis I, Rizzo C, Adebahr S, Kuhn S, Toncheva P, Baltas D, Zamboglou C, Grosu AL, Spohn SKB. PMID: 41958959 [PubMed]
	Clinical management of cancer after kidney transplantation. Front Immunol Hiramitsu T, Ienaga A, Shimamoto Y, Himeno T, Hasegawa Y, Futamura K, Okada M, Narumi S, Watarai Y. PMID: 41958670 [PubMed - indexed for MEDLINE]
	The prognostic value of the lung immune prognostic index in patients with urological cancers: a systematic review and meta-analysis. Front Immunol Lyu Z, Xiao Y, Wang J, Wu R, Yoo KH, Wei W, Zhang Q, Xie Y, Feng D. PMID: 41958645 [PubMed - indexed for MEDLINE]
	Efficacy of androgen deprivation therapy (ADT) in combination with radiation therapy, compared to ADT alone in patients with high-risk prostate cancer: an updated systematic review and meta-analysis. J Med Life Borhan W, Assinnari A, Bakhsh A, Alnazari M, Rajih E. PMID: 41958510 [PubMed - indexed for MEDLINE]
	Comparative analysis of urinary continence recovery after open and laparoscopic radical prostatectomy: a retrospective cohort study. J Med Life Cherciu AI, Persu MC, Bumbea AC, Cherciu MM, Firoiu MC, Vrabie RT, Bolovan E, Arbunea DM, Brînzan DM, Ionescu AI, Bratu OG. PMID: 41958505 [PubMed - indexed for MEDLINE]
	Evaluating BCG response in primary and metachronous non-muscle invasive bladder cancer following prior upper tract urothelial cancer: A systematic review and meta-analysis. Urol Oncol Tan YG, Fong KY, Abern MR, Lim BJH, Leow JJ, Chong TW, Tay KJ, Chen K, Yuen JS, Chan J, Chan JY, Hussain SA, Teoh JY, Kamat AM. PMID: 41956941 [PubMed - as supplied by publisher]
	Evaluating MRI findings and biopsy strategies to maximize detection of grade progression in men on active surveillance for prostate cancer. Urol Oncol Sharifi SHH, Ryan JT, Williams A, Tapia-Stoll N, Bitaraf M, Abdshah A, Soodana-Prakash N, Khandekar A, Swain S, Kryvenko ON, Stoyanova R, Pollack A, Castillo PR, Nahar B, Ritch CR, Kava B, Gonzalgo ML, Parekh DJ, Punnen S. PMID: 41956940 [PubMed - as supplied by publisher]
	Associations Between Quality of Life and Disease Progression in Metastatic Hormone-sensitive Prostate Cancer: Insights from ARASENS and ARANOTE Trials. Eur Urol Oncol Morgans AK, Ekberg S, Boegemann M, Paracha N, Gallagher E, Gasparini A, Crowther MJ, Shore N, Wallis CJD. PMID: 41956912 [PubMed - as supplied by publisher]
	Re: Chase Peng Yun Ng, Alexander Light, Sai Kalpitha Eragamreddy, et al. Five-year Outcomes for Men after Negative Magnetic Resonance Imaging (MRI) or Negative Biopsy in the RAPID MRI-directed Prostate Cancer Diagnostic Pathway. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2025.10.015. Eur Urol Kadam A, Misra A, Prakash G. PMID: 41956860 [PubMed - as supplied by publisher]
	Simlukafusp alfa (FAP-IL2v) plus atezolizumab with or without bevacizumab in unresectable, metastatic renal cell carcinoma: a randomized, open-label phase Ib study. J Immunother Cancer Perez-Gracia JL, Mellado B, Hansen AR, Alonso-Gordoa T, Gomez-Roca C, Løvendahl Eefsen R, Negrier S, Suárez C, Lee JL, Hussain A, Pedrazzoli P, Moreno V, Rodriguez-Vida A, Sosman JA, Waddell T, Bedke J, Park SH, Sznol M, Spychaj L, Andersson E, Julien-Laferriere A, Cheng WY, Watson C, Silva AP, Heichinger C, Staedler N, Sleiman N, Dejardin D, Boetsch C, Evers S, Vardar T, Ardeshir-Tandon C, Dorado Pérez J, Charo J, Keshelava N, Kraxner A, Teichgräber V, Powles T. PMID: 41956546 [PubMed - indexed for MEDLINE]
	DNA repair RAD 18 rs373572 and OGG1 rs1052133 genes polymorphisms association with histological characterization of renal cell carcinoma. Wiad Lek Altemimi IKA, Ameen BAM, Al-Terehi MN, Hussein LM. PMID: 41955591 [PubMed - indexed for MEDLINE]
	Expression of lncRNA-ATB and miR-200c in patients with bladder cancer: a pilot study. Lab Med Kaytaz M, Degirmenci ME, Kucukgergin C, Aydin AF, Sanli O, Erdem S, Ozcan F, Ozluk Y, Dogru Abbasoglu S. PMID: 41955422 [PubMed - indexed for MEDLINE]
	Renal Oncocytic Neoplasms: Review of Classification Updates, Imaging, and Management. Radiographics Akobeng MA, Bhayana R, Di Loreto M, Taffel M, Woo S, Tirumani SH, Shanbhogue K, Prendeville S, Elsayes K, Schieda N, Silverman SG, Krishna S. PMID: 41955128 [PubMed - indexed for MEDLINE]
	Screening policy changes and prostate cancer epidemiology: 20-year trends in diagnosis, treatment, incidence, and mortality. World J Urol Jin S, Xia K, Wang J, Zhang H, Ye YN. PMID: 41954768 [PubMed - indexed for MEDLINE]
	Renal medullary carcinoma: a systematic review of clinical and radiological findings. Int Urol Nephrol Weston W, Sit C, Dafydd DA, Kelly-Morland C, Sohaib A, Adamane S, Manickavasagar T, Pickering L, Nicol D, Withey SJ. PMID: 41954690 [PubMed - as supplied by publisher]
	The Proposed Introduction of a Prostate Cancer Screening Program in Germany: Procedure, Necessary Studies before Implementation, Benefits, and Risks. Dtsch Arztebl Int Albers P, Carlsson S, Krilaviciute A, Seibold P, Becker N. PMID: 41954430 [PubMed - as supplied by publisher]
	Safety, Feasibility and Prognostic Analysis of Surgical Treatment for High-Complexity Renal Tumours (RENAL ScoreÂ â‰¥Â 10): A Summary of Experience With Robotic Technology Applications. Int J Med Robot Xu L, Wang J, Shi Y, Sun G, Zeng H. PMID: 41954116 [PubMed - indexed for MEDLINE]
	Association of EBV infection with increased cancer aggressiveness in prostate cancer patients: A systematic review and meta-analysis. Adv Clin Exp Med Abidi SH, Fabiyi OT, Omarova Z, Sheikh A, Ahmed K, Bajpai R. PMID: 41953983 [PubMed - as supplied by publisher]
	Neoadjuvant Toripalimab Plus Axitinib for Nonmetastatic Clear Cell Renal Cell Carcinoma With Tumor Thrombus: A Combined Analysis of Two Phase II Clinical Trials. MedComm (2020) Peng C, Wu Z, Wang Y, Liang Q, Wang D, Zhao H, Li J, Yue X, Zhang Y, Song J, Shi C, Wang H, Yang G, Wang B, Huang Q, Zhang X, Ma X, Huang J, Gu L. PMID: 41953639 [PubMed]

Articles 1 - 20 / 186926

Page 1 of 9347



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy